标题/作者	年份
Virological assessment of hospitalized patients with COVID-2019 R Wölfel, VM Corman, W Guggemos, M Seilmaier, S Zange, MA Müller, ... Nature 581 (7809), 465-469	2020
Multidisciplinary research priorities for the COVID-19 pandemic: a call for action for mental health science EA Holmes, RC O'Connor, VH Perry, I Tracey, S Wessely, L Arseneault, ... The Lancet Psychiatry 7 (6), 547-560	2020
Features, evaluation, and treatment of coronavirus (COVID-19) M Cascella, M Rajnik, A Aleem, S Dulebohn, R Di Napoli StatPearls	2023
Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor J Lan, J Ge, J Yu, S Shan, H Zhou, S Fan, Q Zhang, X Shi, Q Wang, ... nature 581 (7807), 215-220	2020
Pathophysiology, transmission, diagnosis, and treatment of coronavirus disease 2019 (COVID-19): a review WJ Wiersinga, A Rhodes, AC Cheng, SJ Peacock, HC Prescott Jama 324 (8), 782-793	2020
The trinity of COVID-19: immunity, inflammation and intervention MZ Tay, CM Poh, L Rénia, PA MacAry, LFP Ng Nature Reviews Immunology 20 (6), 363-374	2020
Characteristics of SARS-CoV-2 and COVID-19 B Hu, H Guo, P Zhou, ZL Shi Nature Reviews Microbiology 19 (3), 141-154	2021
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing DE Gordon, GM Jang, M Bouhaddou, J Xu, K Obernier, KM White, ... Nature 583 (7816), 459-468	2020
Tracking changes in SARS-CoV-2 spike: evidence that D614G increases infectivity of the COVID-19 virus B Korber, WM Fischer, S Gnanakaran, H Yoon, J Theiler, W Abfalterer, ... Cell 182 (4), 812-827. e19	2020
Imbalanced host response to SARS-CoV-2 drives development of COVID-19 D Blanco-Melo, BE Nilsson-Payant, WC Liu, S Uhl, D Hoagland, R Møller, ... Cell 181 (5), 1036-1045. e9	2020
Structural basis of receptor recognition by SARS-CoV-2 J Shang, G Ye, K Shi, Y Wan, C Luo, H Aihara, Q Geng, A Auerbach, F Li Nature 581 (7807), 221-224	2020
Pharmacologic treatments for coronavirus disease 2019 (COVID-19): a review JM Sanders, ML Monogue, TZ Jodlowski, JB Cutrell Jama 323 (18), 1824-1836	2020
Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV X Ou, Y Liu, X Lei, P Li, D Mi, L Ren, L Guo, R Guo, T Chen, J Hu, Z Xiang, ... Nature communications 11 (1), 1620	2020
Cell entry mechanisms of SARS-CoV-2 J Shang, Y Wan, C Luo, G Ye, Q Geng, A Auerbach, F Li Proceedings of the National Academy of Sciences 117 (21), 11727-11734	2020
Extrapulmonary manifestations of COVID-19 A Gupta, MV Madhavan, K Sehgal, N Nair, S Mahajan, TS Sehrawat, ... Nature medicine 26 (7), 1017-1032	2020
Structural and functional basis of SARS-CoV-2 entry by using human ACE2 Q Wang, Y Zhang, L Wu, S Niu, C Song, Z Zhang, G Lu, C Qiao, Y Hu, ... Cell 181 (4), 894-904. e9	2020
Renin–angiotensin–aldosterone system inhibitors in patients with Covid-19 M Vaduganathan, O Vardeny, T Michel, JJV McMurray, MA Pfeffer, ... New England Journal of Medicine 382 (17), 1653-1659	2020
SARS-CoV-2 entry factors are highly expressed in nasal epithelial cells together with innate immune genes W Sungnak, N Huang, C Bécavin, M Berg, R Queen, M Litvinukova, ... Nature medicine 26 (5), 681-687	2020
COVID-19 pathophysiology: A review K Yuki, M Fujiogi, S Koutsogiannaki Clinical immunology 215, 108427	2020
Coronavirus biology and replication: implications for SARS-CoV-2 P V’kovski, A Kratzel, S Steiner, H Stalder, V Thiel Nature Reviews Microbiology 19 (3), 155-170	2021

1 - 20

计算机程序会自动估算并确定日期和引用次数。